Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alessandra Fleurent
Observed names:
Alessandra E. Fleurent,
Fleurent, Alessandra
Observed institutions:
Centre Hospitalier Universitaire Vaudois,
Concept Foundation
OpenAlex ID:
A5002411093
Successful Efavirenz Dose Reduction Guided by Therapeutic Drug Monitoring
2011
·
Aurélie Fayet Mello
, Thierry Buclin
, et al.
·
Antiviral Therapy
·
44
Development of new malaria diagnostics: matching performance and need
2016
·
David Bell
, Alessandra E. Fleurent
, et al.
·
Malaria Journal
·
37
PDF
Formative research to optimize pre-eclampsia risk-screening and prevention (PEARLS): study protocol
2025
·
Nicole Minckas
, Alim Swarray-Deen
, et al.
·
Reproductive Health
·
9
Quality testing of mifepristone and misoprostol in 11 countries
2023
·
Jason Bower
, Lester Chinery
, et al.
·
International Journal of Gynecology & Obstetrics
·
9
PDF
Factors Affecting and Strategies to Improve Risk Screening and Prevention of Pre-Eclampsia: A Multi-Country, Mixed-Methods Formative Study
2026
·
Nicole Minckas
, Adana Uloaku Nwameme
, et al.
·
SSRN Electronic Journal
Response: Quality testing of mifepristone and misoprostol in 11 countries
2024
·
Jason Bower
, Lester Chinery
, et al.
·
International Journal of Gynecology & Obstetrics
PDF
MOESM1 of Development of new malaria diagnostics: matching performance and need
2016
·
Bell, David
, Fleurent, Alessandra
, et al.
·
Figshare
MOESM1 of Development of new malaria diagnostics: matching performance and need
2016
·
Bell, David
, Fleurent, Alessandra
, et al.
·
Figshare
Show more works
View as search
Works count:
9
Citation count:
99
H-index:
4
I10-index:
2
Year
Topic
Type
